Please use this identifier to cite or link to this item:
Title: Casein Kinase II: An attractive target for anti-cancer drug design
Authors: Hanif, I.M.
Shazib, M.A.
Ahmad, K.A.
Pervaiz, S. 
Keywords: Apoptosis
Protein Kinase CK2
Issue Date: 2010
Citation: Hanif, I.M., Shazib, M.A., Ahmad, K.A., Pervaiz, S. (2010). Casein Kinase II: An attractive target for anti-cancer drug design. International Journal of Biochemistry and Cell Biology 42 (10) : 1602-1605. ScholarBank@NUS Repository.
Abstract: Casein Kinase II (CK2) is a ubiquitous serine/threonine kinase that is highly conserved in eukaryotic cells. CK2 has been shown to impact cell growth and proliferation, as numerous growth-related proteins are substrates of CK2. More importantly, experimental evidence linking increased expression and activity of CK2 to human cancers underscores the relevance of CK2 biology to cellular transformation and carcinogenesis. Due to the critical regulatory role CK2 plays in cell fate determination in cancer cells, there is a tremendous interest in the development of CK2-specific therapies. Supporting this, recent reports have demonstrated that genetic manipulation of CK2 expression as well as pharmacological inhibition of its enzymatic activity sensitizes cancers to apoptotic stimuli. Here we provide a succinct account of the biology of CK2, its cellular substrates, its pro-survival and pro-proliferation activity, and highlight evidence for its involvement in human cancer. © 2010.
Source Title: International Journal of Biochemistry and Cell Biology
ISSN: 13572725
DOI: 10.1016/j.biocel.2010.06.010
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on May 18, 2023


checked on May 18, 2023

Page view(s)

checked on May 25, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.